Security Snapshot

Acadia Healthcare Company, Inc. - Common Stock (ACHC) Institutional Ownership

CUSIP: 00404A109

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

203

Shares (Excl. Options)

87.24MFull value: 87,239,038 · shares · 30 Sep 2026

Price

$27.50

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-7,715,171
Value change
-$219,211,586
Number of holders
203
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
92,247,071
SEC-reported price per share
$29.51
Insider filing price
$29.51
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • ACHC - Acadia Healthcare Company, Inc. - Common Stock is tracked under CUSIP 00404A109.
  • 203 institutions reported positions in Q3 2026.
  • 9 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 312 to 203 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $3.98BFull value: $3,976,949,426 · USD · 30 Jun 2026
    to
    $2.4BFull value: $2,402,043,601 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 203 institutions filings for Q3 2026.

Open SEC evidence

Security key

00404A109

13F reference period

Q3 2026

13F holders

203

13D/G owners

9

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
9
Security
ACHC
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 15% +35% $408,458,128 +$102,862,640 13,831,925 +34% BlackRock, Inc. 30 Jun 2026
VANGUARD PORTFOLIO MANAGEMENT LLC 5.5% $118,810,979 5,079,563 Vanguard Portfolio Management 31 Mar 2026
FMR LLC 5.5% -17% $157,493,814 -$38,148,017 5,015,727 -19% FMR LLC 30 Jun 2026
VANGUARD CAPITAL MANAGEMENT LLC 5.2% $113,175,719 4,838,637 Vanguard Capital Management 31 Mar 2026
DIMENSIONAL FUND ADVISORS LP 5% $129,207,568 4,698,457 Dimensional Fund Advisors LP 30 Sep 2026
WELLINGTON MANAGEMENT GROUP LLP 2.8% -57% $74,568,843 -$90,747,879 2,582,918 -55% Wellington Management Group LLP 30 Sep 2026
GOLDMAN SACHS GROUP INC 1.6% -70% $37,979,421 -$84,132,758 1,464,126 -69% THE GOLDMAN SACHS GROUP, INC. 31 Mar 2026
T. Rowe Price Investment Management, Inc. 1% $21,032,953 949,569 T. Rowe Price Investment Management, Inc. 31 Mar 2025
Khrom Investments Fund, LP 0.72% -82% $20,532,900 -$142,795,237 653,914 -87% Eric Khrom 30 Jun 2026
As of 30 Sep 2026, 203 institutional investors reported holding
87.24MFull value: 87,239,038 · shares · 30 Sep 2026
shares of Acadia Healthcare Company, Inc. - Common Stock (ACHC). This represents 95% of the company’s total
92.25MFull value: 92,247,071 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
73%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD PORTFOLIO MANAGEMENT LLC 6.1% 5,612,654 0.01% $154,347,985
DIMENSIONAL FUND ADVISORS LP 5.1% 4,698,457 0.02% $129,212,655
FARALLON CAPITAL MANAGEMENT, L.L.C. 5% 4,608,400 0.66% $126,731,000
DME Capital Management, LP 4.8% 4,400,641 3.4% $121,017,628
VANGUARD CAPITAL MANAGEMENT LLC 4.6% 4,214,176 0% $115,889,840
ABRAMS BISON INVESTMENTS, LLC 4.5% 4,165,000 5.8% $114,537,500
STATE STREET CORP 4.2% 3,834,840 0% $105,458,100
CARRONADE CAPITAL MANAGEMENT, LP 4% 3,730,159 6.1% $102,579,000
Jefferies Financial Group Inc. 4% 3,703,240 1.4% $101,839,100
GOLDMAN SACHS GROUP INC 4% 3,674,399 0.01% $101,045,959
WELLINGTON MANAGEMENT GROUP LLP 2.8% 2,582,918 0.01% $71,030,245
FRONTIER CAPITAL MANAGEMENT CO LLC 2.7% 2,532,736 0.74% $69,650,238
DEERFIELD MANAGEMENT COMPANY, L.P. 2.7% 2,493,589 1.1% $68,573,698
MAK CAPITAL ONE LLC 2.6% 2,415,247 11% $66,419,293
GEODE CAPITAL MANAGEMENT, LLC 2.6% 2,413,963 0% $66,396,998
Invesco Ltd. 2.3% 2,122,189 0% $58,360,200
NEUBERGER BERMAN GROUP LLC 2.1% 1,949,533 0.04% $53,657,783
MANGROVE PARTNERS IM, LLC 2.1% 1,918,506 3.5% $52,758,915
P2 Capital Partners, LLC 1.9% 1,774,484 16% $48,798,310
BRAIDWELL LP 1.5% 1,352,693 1.5% $37,199,058
BROWN ADVISORY INC 1.2% 1,083,802 0.05% $29,804,545
Aberdeen Group plc 0.74% 678,378 0.03% $18,655,395
VANGUARD FIDUCIARY TRUST CO 0.67% 616,932 0% $16,965,630
SILVERCREST ASSET MANAGEMENT GROUP LLC 0.64% 593,242 0.11% $16,314,155
Penn Capital Management Company, LLC 0.61% 560,252 1.1% $15,434,182

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
51
Headline period
Q3 2026
Rows shown
1-25 of 51
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 87,239,038 $2,402,043,601 -$219,211,586 $27.50 203
2026 Q2 134,732,202 $3,976,949,426 +$101,550,709 $29.53 312
2026 Q1 132,616,806 $3,099,805,138 +$287,658,750 $23.39 295
2025 Q4 121,647,682 $1,726,239,688 +$3,927,608 $14.19 250
2025 Q3 113,557,143 $2,812,604,893 +$198,610,835 $24.76 267
2025 Q2 106,180,176 $2,409,474,221 +$103,570,855 $22.69 293
2025 Q1 100,196,553 $3,036,849,808 -$83,218,159 $30.32 291
2024 Q4 100,303,061 $3,977,210,670 -$244,355,396 $39.65 303
2024 Q3 98,277,466 $6,230,743,414 +$95,258,322 $63.41 307
2024 Q2 96,702,208 $6,530,554,819 +$227,034,398 $67.54 304
2024 Q1 93,239,072 $7,379,280,140 +$49,334,315 $79.22 316
2023 Q4 92,522,774 $7,193,575,118 +$61,021,151 $77.76 308
2023 Q3 91,495,056 $6,432,157,108 -$110,869,598 $70.31 290
2023 Q2 93,104,775 $7,413,877,644 +$21,836,683 $79.64 278
2023 Q1 92,851,264 $6,708,375,103 +$108,041,522 $72.25 305
2022 Q4 91,395,989 $7,523,912,097 -$147,206,889 $82.32 340
2022 Q3 93,271,335 $7,293,955,259 -$736,918,242 $78.18 310
2022 Q2 93,086,616 $6,296,378,261 +$218,949,542 $67.63 275
2022 Q1 90,403,601 $5,924,313,202 +$5,681,531 $65.53 282
2021 Q4 90,317,634 $5,481,351,744 -$5,797,419 $60.70 270
2021 Q3 90,244,441 $5,754,680,982 +$16,478,124 $63.78 287
2021 Q2 89,996,070 $5,646,410,777 -$40,751,033 $62.75 283
2021 Q1 90,677,699 $5,181,144,725 +$27,794,038 $57.14 266
2020 Q4 90,615,773 $4,553,661,692 -$105,569,972 $50.26 258
2020 Q3 92,936,171 $2,735,093,869 -$55,086,757 $29.48 217
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .